Charanpreet K. Singh

Chandigarh, CH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Published: July 06, 2026

Efficacy and Safety of Novel-Agent-Based Front-Line Therapy in Older Adults Aged ≥ 60 Years With Classic Hodgkin Lymphoma: A Systematic Review and Meta-Analysis.

Efficacy and Safety of Novel-Agent-Based Front-Line Therapy in Older Adults Aged ≥ 60 Years With Classic Hodgkin Lymphoma: A Systematic Review and Meta-Analysis.

Journal: Hematological oncology

Published: May 16, 2026

Lenalidomide exposure duration and drug holidays do not affect stem cell mobilisation with plerixafor and G-CSF in multiple myeloma.

Lenalidomide exposure duration and drug holidays do not affect stem cell mobilisation with plerixafor and G-CSF in multiple myeloma.

Journal: Leukemia & lymphoma

Published: April 01, 2026

Prevalence of Clinically Significant Viral and Bacterial Enteric Pathogens Among Indian Hematopoietic Stem Cell Transplant Recipients and Allogeneic Donors.

Prevalence of Clinically Significant Viral and Bacterial Enteric Pathogens Among Indian Hematopoietic Stem Cell Transplant Recipients and Allogeneic Donors.

Journal: Transplantation and cellular therapy

Published: March 07, 2026

Reversing Transplant Ineligibility With Teclistamab in Ultra-High-Risk Relapsed/Refractory Multiple Myeloma With Extramedullary Disease.

Reversing Transplant Ineligibility With Teclistamab in Ultra-High-Risk Relapsed/Refractory Multiple Myeloma With Extramedullary Disease.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 05, 2026

Non-ICANS neurological toxicities associated with BCMA-directed CAR T-cell therapy in patients with plasma cell dyscrasia: A systematic review and pooled analysis.

Non-ICANS neurological toxicities associated with BCMA-directed CAR T-cell therapy in patients with plasma cell dyscrasia: A systematic review and pooled analysis.

Journal: British journal of haematology

Published: November 21, 2025

Fixed-duration cytarabine consolidation improves relapse-free survival over indefinite AZA-VEN in younger AML.

Fixed-duration cytarabine consolidation improves relapse-free survival over indefinite AZA-VEN in younger AML.

Journal: Blood cancer journal

Published: November 18, 2025

Unusual Infections following Haploidentical Hematopoietic Stem cell Transplant in a Case with severe Aplastic Anaemia'.

Unusual Infections following Haploidentical Hematopoietic Stem cell Transplant in a Case with severe Aplastic Anaemia'.

Journal: Blood cell therapy

Published: September 11, 2025

Menstrual patterns and gonado-sexual health following hematopoietic transplant in reproductive age women and the role of hormone replacement therapy.

Menstrual patterns and gonado-sexual health following hematopoietic transplant in reproductive age women and the role of hormone replacement therapy.

Journal: Blood cell therapy

Published: August 22, 2025

Disseminated Lymphoma Cutis in a Patient with NK T Cell Lymphoma Managed with SMILE Multiagent Chemotherapy.

Disseminated Lymphoma Cutis in a Patient with NK T Cell Lymphoma Managed with SMILE Multiagent Chemotherapy.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: August 09, 2025

Real-World Outcomes of Allogeneic Stem Cell Transplantation in Relapsed Hodgkin Lymphoma: A Single-Center Experience from India.

Real-World Outcomes of Allogeneic Stem Cell Transplantation in Relapsed Hodgkin Lymphoma: A Single-Center Experience from India.

Journal: Blood cell therapy

Published: August 07, 2025

Plasma interleukin-12 levels as a potential biomarker of fatigue and quality of life in patients with primary immune thrombocytopenia.

Plasma interleukin-12 levels as a potential biomarker of fatigue and quality of life in patients with primary immune thrombocytopenia.

Journal: Blood research

Published: July 02, 2025

Showing 1-12 of 114

Last Updated: 09/26/2026